Literature DB >> 1953770

Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx mice.

M Takemitsu1, S Ishiura, R Koga, K Kamakura, K Arahata, I Nonaka, H Sugita.   

Abstract

The amino acid sequence of the polyclonal antibodies we developed against the carboxyl terminus of the dystrophin-related protein, the putative gene product of B3 cDNA, had no homologous sequence to the dystrophin molecule except for two amino acids located at its ends for immunization. By immunohistochemical examination in C57B1/10ScSn and C57B1/10ScSn-mdx mice we found that the DRP was expressed on the surface membrane of fetal muscle fibers, was assembled at the neuromuscular junctions of the mature muscle fibers, and reappeared on the surface membrane of muscle fibers after denervation. Its localization was similar to that of the acetylcholine receptor, suggesting that DRP is one of the cytoskeletons which organize and stabilize the cytoplasmic domain of the acetylcholine receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953770     DOI: 10.1016/s0006-291x(05)81320-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

Review 2.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design.

Authors:  Ava Yun Lin; Ewa Prochniewicz; Davin M Henderson; Bin Li; James M Ervasti; David D Thomas
Journal:  J Mol Biol       Date:  2012-04-11       Impact factor: 5.469

4.  Increased expression of dystrophin, beta-dystroglycan and adhalin in denervated rat muscles.

Authors:  D Biral; L Senter; G Salviati
Journal:  J Muscle Res Cell Motil       Date:  1996-10       Impact factor: 2.698

Review 5.  Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.

Authors:  Guy L Odom; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Biochim Biophys Acta       Date:  2006-09-26

Review 6.  Molecular Therapies for Muscular Dystrophies.

Authors:  Ava Y Lin; Leo H Wang
Journal:  Curr Treat Options Neurol       Date:  2018-06-21       Impact factor: 3.598

7.  Dystrophin and a dystrophin-related protein in intrafusal muscle fibers, and neuromuscular and myotendinous junctions.

Authors:  J Zhao; K Yoshioka; M Miyatake; T Miike
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Dystrophin and dystrophin-related protein in the central nervous system of normal controls and Duchenne muscular dystrophy.

Authors:  M Uchino; H Teramoto; H Naoe; T Miike; K Yoshioka; M Ando
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Dystrophin-related protein in skeletal muscles in neuromuscular disorders: immunohistochemical study.

Authors:  M Takemitsu; I Nonaka; H Sugita
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice.

Authors:  Jamie L Marshall; Eric Chou; Jennifer Oh; Allan Kwok; Dean J Burkin; Rachelle H Crosbie-Watson
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.